AP
TECX

AlpInvest Partners’s Tectonic Therapeutic TECX Stock Holding History

AlpInvest Partners’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-16,728
Closed -$4.04M – 30
2019
Q4 		$4.04M Sell
16,728
-3,587
-18% -$692K 3.44% 11
2019
Q3 		$3.44M Buy
20,315
+7,685
+61% +$1.74M 4.24% 9
2019
Q2 		$2.46M Buy
+12,630
New +$2.72M 2.37% 13

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

AlpInvest Partners's TECX Position: Q1 2020 in Review

AlpInvest Partners sold out of Tectonic Therapeutic (TECX) in Q1 2020, closing a stake of 16,728 shares — an estimated $4.04M sold.

AlpInvest Partners first reported a position in TECX in Q2 2019 and held it in 3 quarters. The position peaked at $4.04M in Q4 2019. 92 funds tracked by Wall St. Rank hold TECX as of Q1 2020.

  • AlpInvest Partners reported no remaining Tectonic Therapeutic position as of Q1 2020 after selling out during the quarter.
  • AlpInvest Partners sold 16,728 Tectonic Therapeutic shares in Q1 2020, an estimated $4.04M.
  • AlpInvest Partners first reported a position in Tectonic Therapeutic in Q2 2019 and held it in 3 quarters.
  • AlpInvest Partners's Tectonic Therapeutic position peaked at $4.04M in Q4 2019.
  • 92 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2020.

Based on AlpInvest Partners's 13F filing for Q1 2020, filed 13 May 2020.